BARDA Hails FDA’s Approval of Flu Vaccine Manufacturing
The first approval to manufacture seasonal influenza vaccine using cell-based technology in a U.S. facility “demonstrates the effectiveness of a multi-use approach to emergency preparedness,” Director Robin Robinson, Ph.D., noted June 17.
Leave a reply →
